Table 1 Characteristics of commercial HSA (available solutions for infusion in France)[29]
From: Specific antioxidant properties of human serum albumin
|  | Human albumin baxter 200 g/l® | Albunorm® | Vialebex® |
|---|---|---|---|
Manufacturer | Baxter | Octapharma | LFB |
Available presentations | Newborns and infants: | ||
| Â | 20% (200 mg/ml): 10 ml vial (2 g) | ||
Adults: | |||
20% (200 mg/ml): | 20% (200 mg/ml): | 20% (200 mg/ml): | |
50 ml vial (10 g) | 50 ml vial (10 g) | 50 ml vial (10 g) | |
100 ml vial (20 g) | 100 ml vial (20 g) | 100 ml vial (20 g) | |
5% (50 mg/ml): | 5% (50 mg/ml): | ||
100 ml vial (5 g) | 250 ml vial (12.5 g) | ||
250 ml vial (12.5 g) | 500 ml vial (25 g) | ||
500 ml vial (25 g) | Â | ||
| Â | Â | 4% (40 mg/ml): | 4% (40 mg/ml): |
100 ml vial (4 g) | 100 ml vial (4 g) | ||
250 ml vial (10 g) | 250 ml vial (10 g) | ||
500 ml vial (20 g) | 500 ml vial (20 g) | ||
Indications (EMA) | Restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and the use of a colloid is appropriate. The choice of albumin rather than an artificial colloid will depend on the clinical situation of the individual patient, based on official recommendations. | ||